AbbVie Inc. (ABBV) Weekly Performance Review: Healthcare (Biotech) Update February 2026
The Weekly Scorecard This week, AbbVie (ABBV) lagged the broader market, posting a modest decline while the S&P 500 (SPY) and Nasdaq (QQQ) remained relatively flat. The stock acted as a laggard, failing to participate in the minor pockets of strength seen elsewhere in the market. This relative weakness is